IMARC Group’s report titled “Enteric Disease Testing Market Report by Product Type (Reagents and Consumables, Equipment), Technique (Molecular Diagnostics, Immunodiagnostics), Disease Type (Bacterial Enteric Disease, Viral Enteric Disease, Parasitic Enteric Disease), End User (Hospital Diagnostic Laboratories, Independent Diagnostic Laboratories, Academic and Research Institutes, and Others), and Region 2024-2032“. The global enteric disease testing market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/enteric-disease-testing-market/requestsample
Factors Affecting the Growth of the Enteric Disease Testing Industry:
- Technological Innovations:
Advancements in diagnostic technologies, such as polymerase chain reaction (PCR)-based assays, immunoassays, and rapid antigen tests, are supporting the market growth. These innovations enhance sensitivity, specificity, and speed of detection, which is crucial for prompt diagnosis and outbreak containment. Furthermore, portable and automated platforms facilitate testing in diverse settings, ranging from clinical laboratories to field deployments, improving accessibility and scalability. Apart from this, key players are offering more reliable and efficient testing solutions that are essential for effective disease management.
- Rising Focus on Food Safety:
The increasing consumer awareness about the importance of food safety testing, along with stringent regulatory measures, is contributing to the growth of the market. In addition, enteric pathogens, such as Salmonella, Campylobacter, and Listeria, pose various risks to public health through contaminated food and water. Consequently, food producers, distributors, and regulatory agencies are prioritizing robust testing protocols to ensure product safety and compliance. Furthermore, key players are providing enteric disease testing solutions tailored as per food industry needs, which is bolstering the market growth.
- Increasing Incidence of Enteric Diseases:
The escalating demand for enteric disease testing on account of the rising prevalence of enteric diseases among the masses across the globe is strengthening the market growth. Poor sanitation, contaminated food, and waterborne pathogens contribute to the spread. Consequently, healthcare systems are prioritizing efficient diagnostics to manage outbreaks, reduce transmission, and ensure timely treatment among individuals. Apart from this, the increasing awareness about the crucial role of testing in epidemiological surveillance and public health interventions is supporting the market growth.
Leading Companies Operating in the Enteric Disease Testing Industry:
- Abbott Laboratories
- BD (Becton, Dickinson and Company)
- Bio-Rad Laboratories Inc.
- Biomerica Inc.
- Biomérieux SA
- Cepheid Inc. (Danaher Corporation)
- Coris BioConcept
- DiaSorin
- Meridian Bioscience Inc.
- Quest Diagnostics
Enteric Disease Testing Market Report Segmentation:
By Product Type:
- Reagents and Consumables
- Equipment
On the basis of the product type, the market has been bifurcated into reagents and consumables and equipment.
By Technique:
- Molecular Diagnostics
- Immunodiagnostics
Molecular diagnostics hold the biggest market share as they offer enhanced sensitivity and specificity in detecting enteric pathogens.
By Disease Type:
- Bacterial Enteric Disease
- C. Difficile
- Campylobacteriosis
- Cholera
- E. Coli
- H. Pylori
- Salmonellosis
- Shigellosis
- Viral Enteric Disease
- Rotavirus
- Norovirus
- Others
- Parasitic Enteric Disease
- Amebiasis
- Cryptosporidiosis
- Giardiasis
Bacterial enteric disease accounts for the largest market share, driven by the rising prevalence of bacterial pathogens, such as Salmonella, Campylobacter, Escherichia coli, Shigella, and Vibrio species.
By End User:
- Hospital Diagnostic Laboratories
- Independent Diagnostic Laboratories
- Academic and Research Institutes
- Others
On the basis of the end user, the market has been divided into hospital diagnostic laboratories, independent diagnostic laboratories, academic and research institutes, and others.
Regional Insights:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Asia Pacific enjoys a leading position in the enteric disease testing market on account of the improving healthcare expenditure.
Global Enteric Disease Testing Market Trends:
Governing agencies of several countries and healthcare providers are allocating resources to improve disease detection, surveillance, and patient care, which is propelling the market growth. This increased investment facilitates the adoption of advanced testing technologies and expands access to diagnostic services, particularly in underserved regions.
Besides this, the growing demand for point-of-care (POC) testing solutions that can deliver rapid and accurate results, particularly in resource-limited settings or during outbreaks, is offering a positive market outlook. POC testing reduces turnaround time for diagnosis and enables prompt treatment. Furthermore, ongoing research and development (R&D) efforts aimed at developing novel diagnostic technologies and expanding the range of detectable pathogens that enable more comprehensive testing capabilities.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
